{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:41:36Z","timestamp":1791099696069,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.yexmp.2007.12.002","type":"journal-article","created":{"date-parts":[[2008,1,7]],"date-time":"2008-01-07T12:17:23Z","timestamp":1199708243000},"page":"79-89","source":"Crossref","is-referenced-by-count":64,"title":["The status and role of ErbB receptors in human cancer"],"prefix":"10.1016","volume":"84","author":[{"given":"I.","family":"\u00dcberall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Kol\u00e1\u0159","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Trojanec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Berkovcov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hajd\u00fach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2007.12.002_bib1","first-page":"155","article-title":"Prognostic and predictive factors in breast cancer by immunohistochemical analysis","volume":"11","author":"Allred","year":"1998","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00401-004-0875-6","article-title":"Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas","volume":"108","author":"Andersson","year":"2004","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib3","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1158\/1078-0432.CCR-04-1633","article-title":"Absence of HER4 expression predicts recurrence of ductal carcinoma in situ of the breast","volume":"11","author":"Barnes","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2007.12.002_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0002-9378(11)80044-X","article-title":"Epidermal growth factor expression in normal ovarian","volume":"164","author":"Berchuck","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib5","first-page":"1","article-title":"Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses","volume":"144","author":"Birtwistle","year":"2007","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib6","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0002-9610(01)00733-4","article-title":"Status of HER-2 in male and female breast carcinoma","volume":"182","author":"Bloom","year":"2001","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.yexmp.2007.12.002_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.2003.10.104","article-title":"Evaluation of monoclonal humanized anti-HER2 antibody, trastuzumab, in patients with recurrent or refractory ovarian or primary peritoneal carcinoma with overexpression of HER2: a phase II trial of the Gynecologic Oncology Group","volume":"21","author":"Bookman","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib8","first-page":"13","article-title":"Immunophenotype of intraductal carcinoma","volume":"28","author":"Bose","year":"2001","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.yexmp.2007.12.002_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1677\/erc.1.01047","article-title":"Role of exon-16-deleted HER2 in breast carcinomas","volume":"13","author":"Castiglioni","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.yexmp.2007.12.002_bib90","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1517\/14796694.1.1.37","article-title":"Cancer biomarkers: knowing the present and predicting the future","volume":"1","author":"Chatterjee","year":"2005","journal-title":"Future Oncol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1042\/bj3240855","article-title":"Receptor dimerization is not a factor in the signaling activity of a transforming variant epidermal growth factor (EGFRvIII)","volume":"324","author":"Chu","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexmp.2007.12.002_bib11","first-page":"81","article-title":"Expression pattern of neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract","volume":"4","author":"Cohen","year":"1989","journal-title":"Oncogene."},{"key":"10.1016\/j.yexmp.2007.12.002_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/6495","article-title":"A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2\/neu tyrosine kinase","volume":"5","author":"Craft","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexmp.2007.12.002_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0046-8177(96)90364-0","article-title":"Immunohistochemical evaluation of HER-2\/neu oncogene expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms","volume":"27","author":"Day","year":"1996","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib14","first-page":"3438","article-title":"Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer","volume":"8","author":"Di Lorenzo","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2007.12.002_bib15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/sj.bjc.6601961","article-title":"Lack of relationships between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group)","volume":"91","author":"Elie","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexmp.2007.12.002_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.canlet.2004.03.037","article-title":"Enhanced TGF\u03b1\u2013EGFR expression and P53 gene alterations contributes to gastric tumor aggressiveness","volume":"212","author":"Espinoza","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexmp.2007.12.002_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/172460080301800308","article-title":"Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC RI or R2) gastric cancer","volume":"18","author":"Garcia","year":"2003","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.yexmp.2007.12.002_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00666182","article-title":"A multiparametric study on the prognostic value of epidermal growth factor receptor in operable breast carcinoma","volume":"29","author":"Gasparini","year":"1994","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.yexmp.2007.12.002_bib19","first-page":"3819","article-title":"Non small lung cancer: ErbB-2 overexpression correlates with low angiogenesis and poor prognosis","volume":"16","author":"Giatromanolaki","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/j.yexmp.2007.12.002_bib20","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1038\/sj.onc.1201447","article-title":"ErbB kinases and NDF signaling in human prostate cancer cells","volume":"15","author":"Grasso","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.yexmp.2007.12.002_bib21","first-page":"181","article-title":"Epidermal growth factor receptor and other oncogenes as prognostic marker","volume":"1992","author":"Harris","year":"1992","journal-title":"J. Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.yexmp.2007.12.002_bib22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1053\/sonc.2002.32899","article-title":"ErbB-2 in breast cancer: development of a clinically useful marker","volume":"29","author":"Hayes","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1098\/rstb.1998.0228","article-title":"The Croonian lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease","volume":"353","author":"Hunter","year":"1998","journal-title":"Phil. Trans. R Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.yexmp.2007.12.002_bib24","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1054\/bjoc.2000.1580","article-title":"Expression and clinical significance of erb-B receptors family in hepatocellular carcinoma","volume":"84","author":"Ito","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexmp.2007.12.002_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1247\/csf.31.1","article-title":"ErbB and HB-EGF signaling in heart development and function","volume":"31","author":"Iwamoto","year":"2006","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.yexmp.2007.12.002_bib26","doi-asserted-by":"crossref","first-page":"17138","DOI":"10.1073\/pnas.0407057101","article-title":"ErbB2 is required for ductal morphogenesis of the mammary gland","volume":"101","author":"Jackson-Fisher","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2007.12.002_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jernal","year":"2005","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexmp.2007.12.002_bib28","doi-asserted-by":"crossref","first-page":"R568","DOI":"10.1016\/S0960-9822(99)80357-1","article-title":"Receptor activation: when a dimer is not enough","volume":"9","author":"Jinag","year":"1999","journal-title":"Curr. Biol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib29","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1200\/JCO.2005.04.8306","article-title":"Epidermal growth factor receptor biology in head and neck cancer","volume":"24","author":"Kalyankrishna","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib30","first-page":"8002","article-title":"Expression of ERBB2 in human gastric carcinomas: relationships between p185ERBB2 expression and the gene amplification","volume":"50","author":"Kameda","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexmp.2007.12.002_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0344-0338(11)80082-8","article-title":"Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas. An immunohistochemical study of 63 cases","volume":"189","author":"Karameris","year":"1993","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.yexmp.2007.12.002_bib32","first-page":"1593","article-title":"Role of immunohistochemical identification of Her2\/neu and detection of variability in overexpression in pancreatic carcinoma","volume":"22","author":"Koka","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.yexmp.2007.12.002_bib33","first-page":"1161","article-title":"Impact of epidermal growth factor (EGF) radioreceptor analysis on long-term survival of gastric cancer patients","volume":"22","author":"Kopp","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.yexmp.2007.12.002_bib34","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0959-8049(01)00096-X","article-title":"Overexpression of ErbB2 protein correlates with disease-stage and chromosomal gain at the ErbB2 locus in non-small cell lung cancer","volume":"37","author":"Kristiansen","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yexmp.2007.12.002_bib35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1677\/erc.0.0080083","article-title":"EGF mutant receptor vIII as a molecular target in cancer therapy","volume":"8","author":"Kuan","year":"2001","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.yexmp.2007.12.002_bib36","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1600-0463.2005.apm_284.x","article-title":"ERBB2 kinase domain mutation in a gastric cancer metastasis","volume":"113","author":"Lee","year":"2005","journal-title":"APMIS"},{"key":"10.1016\/j.yexmp.2007.12.002_bib37","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/ijc.20591","article-title":"Absence of EGFR mutation in the kinase domain is common human cancers besides non small lung cancer","volume":"113","author":"Lee","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexmp.2007.12.002_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF02788354","article-title":"Overexpression of HER2\/neu oncogene in pancreatic cancer correlates with shortened survival","volume":"17","author":"Lei","year":"1995","journal-title":"Int. J. Pancreatol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib39","first-page":"21","article-title":"A potential autocrine loop between heregulin-alpha and ErbB-3 receptor in human prostatic adenocarcinoma","volume":"3","author":"Leung","year":"1997","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib40","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0046-8177(97)90014-9","article-title":"Relationship of a new histological categorization of ductal carcinoma in-situ of the breast with size and the immunohistochemical expression p53, ErbB-2, bcl-2 and ki-67","volume":"28","author":"Mack","year":"1997","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib41","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ijrobp.2003.06.002","article-title":"Signal transduction and oncogenesis by ErbB\/HER receptors","volume":"58\/3","author":"Marmor","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.yexmp.2007.12.002_bib42","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1111\/j.1572-0241.2000.02214.x","article-title":"Activation of epidermal growth factor (EGF) receptor kinase in gastric carcinoma: a preliminary study","volume":"95","author":"Masaki","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jemt.10181","article-title":"Prognostic a predictive value of HER2\/neu oncogene in breast cancer","volume":"59","author":"Masood","year":"2002","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.yexmp.2007.12.002_bib44","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ijrobp.2003.09.093","article-title":"The HER receptor family: a rich target for therapeutic development","volume":"58","author":"Mass","year":"2004","journal-title":"Int. J. Rad. Oncol. Biol. Phys."},{"key":"10.1016\/j.yexmp.2007.12.002_bib45","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1002\/1097-0142(19930415)71:8<2454::AID-CNCR2820710805>3.0.CO;2-2","article-title":"The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer","volume":"71","author":"Mayer","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.yexmp.2007.12.002_bib46","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1183\/09031936.02.00296502","article-title":"The role of EGF-R expression on patient survival in lung cancer: and systematic review with meta-analysis","volume":"20","author":"Meert","year":"2002","journal-title":"Eur. Respir."},{"key":"10.1016\/j.yexmp.2007.12.002_bib47","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ccr.2004.09.031","article-title":"HER2\/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability","volume":"6","author":"Mellinghoff","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexmp.2007.12.002_bib48","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1440-1746.2000.0150121356.x","article-title":"Chronic hepatitis B virus infection in Asian countries","volume":"15","author":"Merican","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib49","first-page":"1088","article-title":"Ductal carcinoma in-situ of the breast: correlation between histologic classification and biologic markers","volume":"10","author":"Moreno","year":"1997","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib50","first-page":"5536","article-title":"Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors","volume":"55","author":"Moscatello","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexmp.2007.12.002_bib51","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/jnci\/86.15.1140","article-title":"Expression of p160 erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma","volume":"86","author":"Myers","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.yexmp.2007.12.002_bib52","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/bjc.1998.689","article-title":"Expression of ErbB-3 protein in primary breast carcinomas","volume":"78","author":"Naidu","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexmp.2007.12.002_bib53","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0959-8049(01)00231-3","article-title":"EGFR and cancer prognosis","volume":"37","author":"Nicholson","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yexmp.2007.12.002_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000011931","article-title":"Mutations and amplification of oncogenes in endometrial cancer","volume":"56","author":"Niederacher","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.yexmp.2007.12.002_bib55","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1073\/pnas.91.16.7727","article-title":"A mutant epidermal growth factor common in human glioma confers enhanced tumorigenicity","volume":"91","author":"Nishikawa","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2007.12.002_bib56","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/emboj\/19.13.3159","article-title":"The ErbB signaling network: receptor heterodimerization in development and cancer","volume":"9","author":"Olayioye","year":"2000","journal-title":"EMBO J."},{"key":"10.1016\/j.yexmp.2007.12.002_bib57","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.yexmp.2007.12.002_bib58","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1200\/JCO.2000.18.16.2948","article-title":"Oncogenes and male breast carcinoma: ErbB-2 and p53 predicts a poor survival","volume":"18","author":"Pich","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<18::AID-IJC5>3.0.CO;2-M","article-title":"Estimates of the worldwide mortality of 25 cancers in 1990","volume":"83","author":"Pisani","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexmp.2007.12.002_bib60","doi-asserted-by":"crossref","first-page":"M199","DOI":"10.1136\/mp.49.4.M199","article-title":"ErbB3 protein expression in ovarian cancer","volume":"49","author":"Rajkumar","year":"1996","journal-title":"Clin. Mol. Pathol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib61","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1309\/VXKK-YVRH-9B11-YDPT","article-title":"HER2 protein expression and gene amplification in androgen independent prostate cancer","volume":"116","author":"Reese","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10555-005-5047-1","article-title":"Biological significance of c-erbB family oncogenes in head and neck cancer","volume":"24","author":"Rogers","year":"2005","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.yexmp.2007.12.002_bib63","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1081\/CNV-100103852","article-title":"The HER-2\/neu oncogene in tumors of the gastrointestinal tract","volume":"19","author":"Ross","year":"2001","journal-title":"Cancer Invest."},{"key":"10.1016\/j.yexmp.2007.12.002_bib64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00441-005-1109-5","article-title":"Endometrial cancer","volume":"322","author":"Ryan","year":"2005","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.yexmp.2007.12.002_bib65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/1040-8428(94)00144-I","article-title":"Epidermal growth factor-related peptides and their receptors in human malignances","volume":"19","author":"Salomon","year":"1995","journal-title":"Crit. Rev. Oncol\/Hematol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib66","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/MCB.21.13.4265-4275.2001","article-title":"HER4 mediates ligand-independent antiproliferative and differentiation responses in human breast cancer cells","volume":"21","author":"Sartor","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib67","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0002-9440(10)64377-5","article-title":"Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer","volume":"160","author":"Savinainen","year":"2002","journal-title":"Am. J. Pathol."},{"issue":"23","key":"10.1016\/j.yexmp.2007.12.002_bib68","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1200\/JCO.2004.00.117","article-title":"Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies","volume":"22","author":"Scartozzi","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0092-8674(00)00114-8","article-title":"Cell signaling by receptor tyrosine kinases","volume":"103","author":"Schlessinger","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.yexmp.2007.12.002_bib70","first-page":"90","article-title":"A close correlation between ErbB-2 gene amplification and local progression in endometrial adenocarcinoma","author":"Seki","year":"1998","journal-title":"Eur. J. Gynaecol. Oncol"},{"key":"10.1016\/j.yexmp.2007.12.002_bib71","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/pros.20460","article-title":"Epidermal growth factor receptor (ErbB1) expression in prostate cancer progression: correlation with androgen independence","volume":"66","author":"Shah","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.yexmp.2007.12.002_bib72","first-page":"6962","article-title":"Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme","volume":"63","author":"Shinojima","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexmp.2007.12.002_bib73","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/1096-9098(200012)75:4<252::AID-JSO5>3.0.CO;2-2","article-title":"Angiogenesis, p53, ErbB-2 immunoreactivity and clinicopathological features in breast male cancers","volume":"75","author":"Shpitz","year":"2000","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib74","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.yexmp.2007.12.002_bib75","first-page":"1993","article-title":"ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the HSP90 inhibitor geldanamycin","volume":"22","author":"Smith","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.yexmp.2007.12.002_bib76","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/jnci\/92.23.1918","article-title":"Her-2-neu expression and progression toward androgen independence in human prostate cancer","volume":"92","author":"Signoretti","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.yexmp.2007.12.002_bib77","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1200\/JCO.2000.18.2.267","article-title":"HER-2\/neu amplification in benign breast disease and the risk of subsequent breast cancer","volume":"18","author":"Stark","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib78","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/431525b","article-title":"Lung cancer: intragenic ErbB2 kinase mutations in tumours","volume":"431","author":"Stephens","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.yexmp.2007.12.002_bib79","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10911-006-9015-3","article-title":"ErbB receptor negative regulatory mechanisms: implication in cancer","volume":"11","author":"Sweeney","year":"2006","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.yexmp.2007.12.002_bib80","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1023\/A:1005824802617","article-title":"The autocrine loop of TGF-alfa\/EGFR and brain tumors","volume":"35","author":"Tang","year":"1997","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ijc.10880","article-title":"Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells","volume":"104","author":"Thomas","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.yexmp.2007.12.002_bib82","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1078-0432.1167.11.3","article-title":"The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers","volume":"11","author":"Tokumo","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2007.12.002_bib83","first-page":"343","article-title":"ErbB-2 gene expression in colorectal cancer","volume":"60","author":"Tsioulias","year":"1990","journal-title":"Jpn. J. Exp. Med."},{"key":"10.1016\/j.yexmp.2007.12.002_bib84","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1535-6108(04)00033-9","article-title":"Focus on gastric cancer","volume":"5","author":"Ushijima","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexmp.2007.12.002_bib85","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/01.MP.0000022251.61944.1D","article-title":"Male breast carcinoma. Correlation of ER, PR, Ki-67, Her-2-Neu and p53 with treatment and survival, a study of 65 cases","volume":"15","author":"Wang-Rodriguez","year":"2002","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib86","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s004320000195","article-title":"Gastric adenocarcinoma: pathomorphology and molecular pathology","volume":"12","author":"Werner","year":"2001","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib87","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/13550289809114515","article-title":"The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target","volume":"4","author":"Wikstrand","year":"1998","journal-title":"J. Neurovirology"},{"key":"10.1016\/j.yexmp.2007.12.002_bib88","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/modpathol.3880503","article-title":"Amplification of Her-2\/neu gene in Her-2\/neu-overexpressing and -nonexpressing breast carcinoma and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material","volume":"15","author":"Xu","year":"2002","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.yexmp.2007.12.002_bib89","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat. Rev."}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480007001463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480007001463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T18:07:26Z","timestamp":1684174046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480007001463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":90,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0014480007001463"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2007.12.002","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}